ABBOTT LABORATORIES Annual Return On Equity in % from 2011 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Abbott Laboratories quarterly/annual Return On Equity history and growth rate from 2011 to 2023.
  • Abbott Laboratories Return On Equity for the quarter ending September 30, 2024 was 14.7 %, a 5.85% increase year-over-year.
  • Abbott Laboratories annual Return On Equity for 2023 was 15.1 %, a 20.7% decline from 2022.
  • Abbott Laboratories annual Return On Equity for 2022 was 19.1 %, a 6.46% decline from 2021.
  • Abbott Laboratories annual Return On Equity for 2021 was 20.4 %, a 42.9% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 15.1 -3.96 -20.7% Jan 1, 2023 Dec 31, 2023
2022 19.1 -1.32 -6.46% Jan 1, 2022 Dec 31, 2022
2021 20.4 +6.13 +42.9% Jan 1, 2021 Dec 31, 2021
2020 14.3 +2.62 +22.4% Jan 1, 2020 Dec 31, 2020
2019 11.7 +4.03 +52.8% Jan 1, 2019 Dec 31, 2019
2018 7.64 +6.13 +407% Jan 1, 2018 Dec 31, 2018
2017 1.51 -5.22 -77.6% Jan 1, 2017 Dec 31, 2017
2016 6.73 -13.5 -66.7% Jan 1, 2016 Dec 31, 2016
2015 20.2 +10.2 +103% Jan 1, 2015 Dec 31, 2015
2014 9.95 -0.99 -9.05% Jan 1, 2014 Dec 31, 2014
2013 10.9 -12 -52.3% Jan 1, 2013 Dec 31, 2013
2012 22.9 +4.09 +21.7% Jan 1, 2012 Dec 31, 2012
2011 18.8 Jan 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.